Related Experiment Video
Updated: Aug 12, 2026
08:42
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Anesthesia for severe mitral and tricuspid regurgitation
1Department of Small Animal Clinical Sciences, Michigan State University College of Veterinary Medicine, East Lansing.
Summary
Anesthesia for mitral or tricuspid regurgitation requires maintaining cardiac output by reducing vascular resistance and preserving venous return. Preferred anesthetic agents include isoflurane, halothane, or opioids, avoiding bradycardia.
Area of Science:
- Cardiology
- Anesthesiology
Background:
- Mitral and tricuspid regurgitation pose unique challenges during anesthesia.
- Maintaining adequate cardiac output is critical for patients with valvular heart disease.
Purpose of the Study:
- To outline anesthetic strategies for patients with mitral or tricuspid regurgitation.
- To emphasize the importance of preserving cardiac output and venous return.
Main Methods:
- Review of anesthetic principles for valvular heart disease.
- Discussion of hemodynamic management and anesthetic agent selection.
Main Results:
- Anesthetic management should focus on decreasing systemic and pulmonary vascular resistance.
- Maintaining adequate venous return is essential.
- A moderate heart rate increase can be beneficial for mitral regurgitation, while bradycardia should be avoided.
Conclusions:
- Anesthetic strategies for mitral or tricuspid regurgitation must prioritize hemodynamic stability.
- Isoflurane, halothane, or opioid-based anesthesia are suitable choices.
- Careful monitoring and management of heart rate and vascular resistance are key.
Related Concept Videos
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...